Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 20 di 60
Titolo Data di pubblicazione Autore(i) File
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. 2010 Malavasi F; Deaglio S; Zaccarello G; Horenstein A; Chillemi A; Audrito V; Serra S; Gandione M; Zitella A; Tizzani A
A novel role of the CX(3)CR1/CX(3)CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. 2011 Ferretti E; Bertolotto M; Deaglio S; Tripodo C; Ribatti D; Audrito V; Blengio F; Matis S; Zupo S; Rossi D; Ottonello L; Gaidano G; Malavasi F; Pistoia V; Corcione A
Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network. 2011 Audrito V; Vaisitti T; Rossi D; Gottardi D; D'Arena G; Laurenti L; Gaidano G; Malavasi F; Deaglio S
CD38 in chronic lymphocytic leukemia: from bench to bedside? 2011 Deaglio S; Vaisitti T; Serra S; Audrito V; Bologna C; D'Arena G; Laurenti L; Gottardi D; Malavasi F
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. 2011 Vaisitti T; Audrito V; Serra S; Bologna C; Brusa D; Malavasi F; Deaglio S
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 2011 Audrito, Valentina; Vaisitti, Tiziana; Rossi, Davide; Gottardi, Daniela; D'Arena, Giovanni; Laurenti, Luca; Gaidano, Gianluca; Malavasi, Fabio; Deaglio, Silvia
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES. 2012 Isoardo G; Morra I; Chiarle G; Audrito V; Deaglio S; Melcarne A; Junemann C; Naddeo M; Cogoni M; Valentini MC; Limberti A; Faccani F; Malavasi F; Faccani G.
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 2012 Bologna C; Buonincontri R; Serra S; Vaisitti T; Audrito V; Brusa D; Rossi D; Coscia M; Gaidano G; Terhorst C; Deaglio S
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 2012 Audrito, Valentina; Vaisitti, Tiziana; Serra, Sara; Rossi, Davide; D'Arena, Giovanni; Laurenti, Luca; Gaidano, Gianluca; Malavasi, Fabio; Deaglio, Silvia
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 2012 Cinzia Bologna; Roberta Buonincontri; Sara Serra; Tiziana Vaisitti; Valentina Audrito; Davide Brusa; Davide Rossi; Marta Coscia; Gianluca Gaidano; Cox Terhorst; Silvia Deaglio
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 2013 Vaisitti T, Audrito V, Serra S, Social G, Zucchetto A, Tissino E, Pagnani A, Vitale C, Coscia M, Gattei V, Bruzzone S, Deaglio S
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 2013 Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S.
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 2013 Audrito, Valentina; Serra, Sara; Vaisitti, Tiziana; Raffaelli, Nadia; Laurenti, Luca; D'Arena, Giovanni; Rossi, Davide; Gaidano, Gianluca; Rizzi, Menico; Deaglio, Silvia
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options. 2013 Audrito V; Vaisitti T; Serra S; Bologna C; Brusa D; Malavasi F; Deaglio S.
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 2014 Audrito, V; Serra, S; Brusa, D; Mazzola, F; Arruga, F; Vaisitti, T; Coscia, M; Maffei, R; Rossi, D; Wang, T; Inghirami, G; Rizzi, M; Gaidano, G; Wolberger, C; Raffaelli, N; Deaglio, S
HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism 2014 R. Rizzo;V. Audrito;P. Vacca;D. Rossi;D. Brusa;M. Stignani;D. Bortolotti;G. D' Arena;M. Coscia;L. Laurenti;F. Forconi;G. Gaidano;M. C. Mingari;L. Moretta;F. Malavasi;S. Deaglio
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 2014 Massi D1; Brusa D2; Merelli B3; Ciano M2; Audrito V4; Serra S4; Buonincontri R4; Baroni G1; Nassini R5; Minocci D5; Cattaneo L6; Tamborini E7; Carobbio A8; Rulli E9; Deaglio S4; Mandalà M10.
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. 2015 Fiorcari S1; Martinelli S1; Bulgarelli J1; Audrito V2; Zucchini P1; Colaci E1; Potenza L1; Narni F1; Luppi M1; Deaglio S2; Marasca R3; Maffei R1.
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. 2015 Vaisitti T; Audrito V; Serra S; Buonincontri R; Sociali G; Mannino E; Pagnani A; Zucchetto A; Tissino E; Vitale C; Coscia M; Usai C; Pepper C; Gattei V; Bruzzone S; Deaglio S.
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 2015 Massi, D.; Brusa, D.; Merelli, B.; Falcone, C.; Xue, G.; Carobbio, A.; Nassini, R.; Baroni, G.; Tamborini, E.; Cattaneo, L.; Audrito, V.; Deaglio, S.; Mandalã , Mario
Mostrati risultati da 1 a 20 di 60
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile